Thermo Fisher Bioproduction Insights
-
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy
2/6/2026
The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.
-
Integrated Upstream And Downstream Strategies For Robust mAb Manufacturing
2/5/2026
Process robust mAb production requires understanding scale dependent cell environments, leveraging predictive models, and pursuing data driven control to minimize variability, optimize quality, and ensure reliable technology transfer across biomanufacturing scales.
-
High Purity Alcohols In Biopharma: Insights In Navigating Compliance
1/14/2026
Learn how to mitigate supply chain risks for industrial alcohols and ensure workplace safety through rigorous tracking and reporting protocols.
-
Avoid CapEX With Improved Operational Efficiencies
1/14/2026
Avoid massive capital expenditures by optimizing supply chain logistics. Learn how off-site material sampling and just-in-time delivery reduce lead times from eight weeks to a single day.
-
Exploring NK Cells And TILs: Emerging Strategies In Immunotherapy
11/14/2025
Explore the rise of NK cell and TIL therapies as next-generation immunotherapies. Understand their unique benefits, limitations, and the manufacturing challenges that must be overcome for patient access.
-
Rethinking Peptones As First-Line Optimization Tools
11/14/2025
Peptones enhance CHO cell growth, viability, and yield, offering a fast, low-risk way to improve bioprocess performance without major process changes.
-
Multispecific Antibodies: Key Challenges And Solutions To Enable A New Frontier In Cancer Treatment
11/14/2025
Multispecific antibodies are a newer class of cancer therapeutics addressing tumor complexity. Learn about the design, manufacturing, and regulatory challenges and integrated solutions accelerating their development.
-
Industry 5.0: Preparing For The Future Of Biotechnology
11/14/2025
Industry 5.0 represents the next generation of bioproduction—the Adaptive Plant—where human expertise is empowered by AI-enabled insights, autonomous systems, and strategic collaboration.
-
What You Should Expect From Your Cell Culture Media Supplier
11/14/2025
Discover how a superior cell culture media supplier provides a VIP experience through seamless ordering, proactive demand planning, and customization to accelerate your project to market.
-
Develop A Cost-Effective cGMP Chemical Sourcing Strategy
11/4/2025
Outsourcing your cGMP chemical supply chain can significantly reduce capital and operating expenses, minimize production delays, and boost manufacturing productivity through improved sourcing and logistics.